Actos Buyers Head To 2nd Circ. After Pay-For-Delay Suit Nixed
Buyers of the diabetes drug Actos on Thursday told a New York federal judge, who last month dismissed their pay-for-delay suit against Takeda and five generic drugmakers, that they are appealing...To view the full article, register now.
Already a subscriber? Click here to view full article